Oramed Pharmaceuticals (ORMP) Deferred Taxes (2017 - 2026)

Oramed Pharmaceuticals (ORMP) posted Deferred Taxes of -$9.8 million for Q1 2026, down 98460.0% on a QoQ basis from $10000.0 in Q4 2025.

Oramed Pharmaceuticals (ORMP) Deferred Taxes (2017 - 2026) Analysis & Trends

Oramed Pharmaceuticals' Deferred Taxes history runs 5 years deep, the most recent figure standing at -$9.8 million for Q1 2026.

Quarterly Deferred Taxes changed N/A year-over-year to -$9.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.2 million (changed N/A YoY) and the FY2025 annual result came in at -$7.9 million, changed N/A from the prior year.
Deferred Taxes was -$9.8 million for Q1 2026 at Oramed Pharmaceuticals, down from $10000.0 in the prior quarter.
Across five years, Deferred Taxes topped out at $10000.0 in Q4 2025 and bottomed at -$9.8 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-188,883.60
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-65.30 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	96.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Oramed Pharmaceuticals	170.25 Mn	170.25 Mn	-	-9.84 Mn

Download Data